Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Aug 9, 2022 · 10-Q · 40 days after period end · 0001213900-22-045922
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$8.54M | -$12.78M | -$7.14M | -$5.32M |
| EPS Diluted | -$0.76 | -$1.14 | -$1.22 | -$0.56 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 9, 2022 · 40 d after period end
